3 September 2021
Cosentyx (Secukinumab) has been recommended for the treatment of severe psoriasis in children and young people (aged 6 to 17 years) in England and Wales.
1 September 2021
Bimzelx (Bimekizumab) has been recommended for the treatment of severe psoriasis in adults in England and Wales.
19 August 2021
Information for people living with psoriasis and psoriatic arthritis, including those taking immunosuppressive medicines.
19 August 2021
Advice for people who are deemed to be 'clinically extremely vulnerable'.
17 August 2021
Information about the COVID-19 vaccine(s), psoriasis and immunosuppressant medications.